Jagdeep Nanchahal

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Topics

Top Venues

The Journal of hand surgery, European volume

Nature communications

Wellcome open research

NIHR open research

This page only lists publications with an associated author ORCID identifier.

Publications

Sophie A Riesmeijer, Zoha Kamali, Michael T H Ng, Dmitriy Drichel, Bram Piersma, Kerstin Becker, Thomas B Layton, Jagdeep Nanchahal, Michael Nothnagel, Ahmad Vaez, Hans Christian Hennies, Paul M N Werker, Dominic Furniss, Ilja Maria Nolte
A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease. Nature communications 15 (1) (2024)
Sophie A Riesmeijer, Zoha Kamali, Michael T H Ng, Dmitriy Drichel, Bram Piersma, Kerstin Becker, Thomas B Layton, Jagdeep Nanchahal, Michael Nothnagel, Ahmad Vaez, Hans Christian Hennies, Paul M N Werker, Dominic Furniss, Ilja Maria Nolte
A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease. Nature communications 15 (1) (2024)
Sophie A Riesmeijer, Zoha Kamali, Michael T H Ng, Dmitriy Drichel, Bram Piersma, Kerstin Becker, Thomas B Layton, Jagdeep Nanchahal, Michael Nothnagel, Ahmad Vaez, Hans Christian Hennies, Paul M N Werker, Dominic Furniss, Ilja Maria Nolte
A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease. Nature communications 15 (1) (2024)
Sophie A Riesmeijer, Zoha Kamali, Michael T H Ng, Dmitriy Drichel, Bram Piersma, Kerstin Becker, Thomas B Layton, Jagdeep Nanchahal, Michael Nothnagel, Ahmad Vaez, Hans Christian Hennies, Paul M N Werker, Dominic Furniss, Ilja Maria Nolte
A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease. Nature communications 15 (1) (2024)
Jagdeep Nanchahal, James K-K Chan
Treatments for early-stage Dupuytren's disease: an evidence-based approach. The Journal of hand surgery, European volume 48 (3) (2023)
Jagdeep Nanchahal, James K-K Chan
Treatments for early-stage Dupuytren's disease: an evidence-based approach. The Journal of hand surgery, European volume 48 (3) (2023)
Jagdeep Nanchahal, James K-K Chan
Treatments for early-stage Dupuytren's disease: an evidence-based approach. The Journal of hand surgery, European volume 48 (3) (2023)
Jagdeep Nanchahal, James K-K Chan
Treatments for early-stage Dupuytren's disease: an evidence-based approach. The Journal of hand surgery, European volume 48 (3) (2023)
Jagdeep Nanchahal, James K-K Chan
Treatments for early-stage Dupuytren's disease: an evidence-based approach. The Journal of hand surgery, European volume 48 (3) (2023)
Jagdeep Nanchahal, James K-K Chan
Treatments for early-stage Dupuytren's disease: an evidence-based approach. The Journal of hand surgery, European volume 48 (3) (2023)
Sally Hopewell, Nicola Kenealy, Ruth Knight, Amar Rangan, Susan Dutton, Cynthia Srikesavan, Marc Feldmann, Sarah Lamb, Jagdeep Nanchahal
Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial. NIHR open research 2 (2023)
Jagdeep Nanchahal, James K-K Chan
Treatments for early-stage Dupuytren's disease: an evidence-based approach. The Journal of hand surgery, European volume (2023)
Matthew Lee Costa, Juul Achten, Ruth Knight, May Ee Png, Julie Bruce, Susan J Dutton, Jason Madan, Karan Vadher, Melina Dritsaki, James Masters, Louise M Spoors, Marta Campolier, Nicholas Parsons, Miguel Antonio Fernandez, Suzanne Jones, Richard Grant, Jagdeep Nanchahal
Negative-pressure wound therapy compared with standard dressings following surgical treatment of major trauma to the lower limb: the WHiST RCT. Health technology assessment (Winchester, England) 24 (38) (2021)
João L Lagarto, Mohammad B Nickdel, Douglas J Kelly, Andrew Price, Jagdeep Nanchahal, Chris Dunsby, Paul French, Yoshifumi Itoh
Autofluorescence Lifetime Reports Cartilage Damage in Osteoarthritis. Scientific reports 10 (1) (2020)
Thomas B Layton, Lynn Williams, Huw Colin-York, Fiona E McCann, Marisa Cabrita, Sir Marc Feldmann, Cameron Brown, Weilin Xie, Marco Fritzsche, Dominic Furniss, Jagdeep Nanchahal
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states. Biology open 9 (3) (2020)
Thomas B Layton, Lynn Williams, Fiona E McCann, Mingjun Zhang, Marco Fritzsche, Huw Colin-York, Marisa Cabrita, Michael T H Ng, Marc Feldmann, Stephen N Sansom, Dominic Furniss, Weilin Xie, Jagdeep Nanchahal
Cellular census of human fibrosis defines functionally distinct stromal cell types and states. Nature communications 11 (1) (2020)
Thomas B Layton, Lynn Williams, Fiona E McCann, Mingjun Zhang, Marco Fritzsche, Huw Colin-York, Marisa Cabrita, Michael T H Ng, Marc Feldmann, Stephen N Sansom, Dominic Furniss, Weilin Xie, Jagdeep Nanchahal
Author Correction: Cellular census of human fibrosis defines functionally distinct stromal cell types and states. Nature communications 11 (1) (2020)
May Ee Png, Melina Dritsaki, Alastair M Gray, Rafael Pinedo-Villanueva, Oliver Rivero-Arias, Jagdeep Nanchahal
Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome open research 3 (2019)
May Ee Png, Melina Dritsaki, Alastair M Gray, Rafael Pinedo-Villanueva, Oliver Rivero-Arias, Jagdeep Nanchahal
Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren's disease: Repurposing Anti-TNF for Treating Dupuytren's Disease (RIDD). Wellcome open research (2019)
Thomas Layton, Jagdeep Nanchahal
Recent advances in the understanding of Dupuytren's disease. F1000Research 8 (2019)
David Izadi, Thomas B Layton, Lynn Williams, Fiona E McCann, Marisa Cabrita, Ana I Espirito Santo, Weilin Xie, Marco Fritzsche, Huw Colin-York, Marc Feldmann, Kim S Midwood, Jagdeep Nanchahal
Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis. Science advances 5 (12) (2019)
Jagdeep Nanchahal, Anastasiya Sybirna, Jennifer Swettenham, Susan Dutton, Vicki S Barber, Joanna Black, Bethan Copsey, Melina Dritsaki, Peter Taylor, Alastair M Gray, Marc Feldmann, Sarah Lamb
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study. Wellcome open research 2 (2017)
Jagdeep Nanchahal, Anastasiya Sybirna, Jennifer Swettenham, Susan Dutton, Vicki S Barber, Joanna Black, Bethan Copsey, Melina Dritsaki, Peter Taylor, Alastair M Gray, Marc Feldmann, Sarah Lamb
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study. Wellcome open research (2017)